Capula Management LTD Seagen Inc. Transaction History

Capula Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$191.51 - $216.16 $13.2 Million - $14.9 Million	69,000 New	69,000 $14.6 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $434,216 - $578,153	3,210 New	3,210 $439,000
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $1.1 Million - $1.47 Million	-7,703 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $863,246 - $1.03 Million	6,060 Added 368.84%	7,703 $1.31 Million
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $221,936 - $264,687	1,643 New	1,643 $259,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.